|Ask||7.13 x 200|
|Day's Range||3.55 - 3.64|
|52 Week Range||2.41 - 7.39|
|PE Ratio (TTM)||-0.81|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Companies in the News are: HCOM,CBB,KOOL,MYCC,APO,CETV
Rancho Cordova-based regenerative medicine company Cesca Therapeutics Inc. is acquiring SynGen Inc., a Sacramento-based developer of cellular processing technology. Under the deal, SynGen's assets will be folded into Cesca (KOOL) subsidiary Thermogenesis Corp., Cesca said in a news release Monday. SynGen shareholders will receive $1 million in cash and 20 percent of ThermoGenesis's common stock.
Cesca Therapeutics Inc. shares surged 11% in premarket trade Monday, after the provider of automated cell processing and point-of-care, autologous cell-based therapies said its wholly-owned unit ThermoGenesis ...